|
|
- Info
Sep
-
Studies find general mechanism of cellular aging; suggest tumor suppressor gene is key
-
CHAPEL HILL – Three separate studies involving researchers from the University of North Carolina at Chapel Hill confirm a gene that suppresses tumor cell growth also plays a key role in aging.
-
UNC testing new treatment for Barrett’s esophagus
-
CHAPEL HILL – UNC Hospitals is leading a nationwide clinical trial to compare the effectiveness of radiofrequency ablation against standard treatment for Barrett’s esophagus, a condition that can lead to deadly gastrointestinal cancer.
-
Chatham Hospital names longtime UNC Health Care official its new CEO
-
CHAPEL HILL – Chatham Hospital in Siler City, N.C., has named Carol B. Straight its new chief executive officer, effective immediately. The Chatham Board of Directors appointed Straight last week.
-
UNC symposium examines role of bacteria in health and disease
-
A Friday (Sept. 22) symposium sponsored by the UNC School of Medicine will examine the role of commensal bacteria - those that populate the human body -- in health and disease.
-
UNC receives $21.3 million Gates Foundation grant to develop new drugs for African sleeping sickness and leishmaniasis
-
CHAPEL HILL – The University of North Carolina at Chapel Hill has received a $21.3 million grant from the Bill & Melinda Gates Foundation to develop effective, inexpensive drugs to treat late-stage African sleeping sickness and visceral leishmaniasis – diseases that infect and kill hundreds of thousands of people in developing nations.
-
UNC presents community conference on genetics and human values
-
CHAPEL HILL – The University of North Carolina at Chapel Hill will host a community genetics forum aimed at engaging the public in discussions about advances in genetics research and promoting community conversations about scientific, health and ethical issues in genetics.
-
UNC Kidney Center receives grant for membranous glomerulopathy study
-
Investigators at the UNC Kidney Center have received a $151,733 grant from the Halpin Foundation to support research on membranous glomerulopathy, a kidney disease.
-
Preeclampsia, fetal development problems may be linked to low levels of hormone
-
CHAPEL HILL – New research from the University of North Carolina at Chapel Hill ties low levels of a hormone secreted by the uterus and embryos to problems with pregnancy and fetal development.
-
Free prostate examinations offered Sept. 27-28 at UNC Hospitals’ Urology Clinic
-
CHAPEL HILL – UNC Health Care urologists will offer free prostate examinations to members of the public 1 p.m. to 7 p.m. Sept. 27 and 28.
-
Ramsden receives Leukemia & Lymphoma Society Scholar Award for 2006
-
Dr. Dale Ramsden, assistant professor of biochemistry and biophysics in the UNC School of Medicine and a UNC Lineberger Comprehensive Cancer Center researcher, has won the 2006 Leukemia & Lymphoma Society Career Development Scholar Award.
-
Strahl named 2006 recipient of Jefferson-Pilot Award
-
Dr. Brian Strahl, assistant professor of biochemistry and biophysics in the UNC School of Medicine, has been named a 2006 Jefferson-Pilot Fellow by the UNC School of Medicine.
|